Literature DB >> 9871470

Expression of the kynurenine enzymes in macrophages and microglial cells: regulation by immune modulators.

D Alberati-Giani1, A M Cesura.   

Abstract

The regulation of the expression of indoleamine 2,3-dioxygenase (IDO) was studied in cloned murine macrophages (MT2) and microglial (N11) cells. Both cell lines express IDO and inducible nitric oxide synthase activity after interferon-gamma (IFN-gamma) stimulation. The regulation of IDO expression appears to differ in the two cell lines. Nitric oxide (NO) production negatively modulates the expression of IDO activity in IFN-gamma-primed macrophages, thereby indicating a cross-talk between the kynurenine and nitridergic pathways in these cells. Conversely, this down-regulation of IDO activity by NO does not occour in microglial cells. A differential regulation of IDO expression in the two cell lines was also observed with LPS and picolinic acid. Together with previous findings, these results indicate the existence of marked differences in the regulation of the expression of the kynurenine pathway enzymes between macrophages and microglial cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9871470     DOI: 10.1007/bf01345271

Source DB:  PubMed          Journal:  Amino Acids        ISSN: 0939-4451            Impact factor:   3.520


  10 in total

Review 1.  Does nitric oxide play a role in maternal tolerance towards the foetus?

Authors:  A González; A S López; E Alegre; J L Alcázar; N López-Moratalla
Journal:  J Physiol Biochem       Date:  2004-09       Impact factor: 4.158

2.  Inflammation-induced catabolism of tryptophan and tyrosine in acute ischemic stroke.

Authors:  Heidi Ormstad; Robert Verkerk; Hans Christian D Aass; Karl-Friedrich Amthor; Leiv Sandvik
Journal:  J Mol Neurosci       Date:  2013-08-30       Impact factor: 3.444

3.  Role of kynurenines in the neurotoxic actions of kainic acid.

Authors:  W M Behan; T W Stone
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

Review 4.  Involvement of quinolinic acid in AIDS dementia complex.

Authors:  Gilles J Guillemin; Stephen J Kerr; Bruce J Brew
Journal:  Neurotox Res       Date:  2005       Impact factor: 3.911

5.  The role of tryptophan catabolism along the kynurenine pathway in acute ischemic stroke.

Authors:  Raf Brouns; Robert Verkerk; Tony Aerts; Didier De Surgeloose; Annick Wauters; Simon Scharpé; Peter P De Deyn
Journal:  Neurochem Res       Date:  2010-05-19       Impact factor: 3.996

6.  Spatio-temporal differences in the profile of murine brain expression of proinflammatory cytokines and indoleamine 2,3-dioxygenase in response to peripheral lipopolysaccharide administration.

Authors:  Caroline André; Jason C O'Connor; Keith W Kelley; Jacques Lestage; Robert Dantzer; Nathalie Castanon
Journal:  J Neuroimmunol       Date:  2008-07-23       Impact factor: 3.478

7.  Potential Mechanism of Cellular Uptake of the Excitotoxin Quinolinic Acid in Primary Human Neurons.

Authors:  Nady Braidy; Hayden Alicajic; David Pow; Jason Smith; Bat-Erdene Jugder; Bruce J Brew; Joseph A Nicolazzo; Gilles J Guillemin
Journal:  Mol Neurobiol       Date:  2020-09-06       Impact factor: 5.590

8.  Tryptophan, Neurodegeneration and HIV-Associated Neurocognitive Disorder.

Authors:  Nicholas W S Davies; Gilles Guillemin; Bruce J Brew
Journal:  Int J Tryptophan Res       Date:  2010-06-10

9.  A biological pathway linking inflammation and depression: activation of indoleamine 2,3-dioxygenase.

Authors:  David M Christmas; Jp Potokar; Simon Jc Davies
Journal:  Neuropsychiatr Dis Treat       Date:  2011-07-13       Impact factor: 2.570

Review 10.  Remarkable role of indoleamine 2,3-dioxygenase and tryptophan metabolites in infectious diseases: potential role in macrophage-mediated inflammatory diseases.

Authors:  Yuki Murakami; Masato Hoshi; Yukio Imamura; Yuko Arioka; Yasuko Yamamoto; Kuniaki Saito
Journal:  Mediators Inflamm       Date:  2013-02-18       Impact factor: 4.711

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.